Vieworks Wins FDA Approval for Its Newest VIVIX-S F series

ANYANG, South Korea, Aug. 5, 2022 /PRNewswire/ -- Vieworks, a leading digital X-ray imaging solution provider based in South Korea, noted that its newest VIVIX-S F series has been authorized by the US Food and Drug Administration (FDA) last July. Regulatory clearance from the FDA will allow Vieworks to commercialize its new VIVIX-S F series, which is Vieworks' premium static X-ray DR flat panel detectors equipped with advanced technology and cutting-edge hardware design. The cassette-sized DR detectors are offered in 3 sizes – 25x30cm (VIVIX-S 2530FW), 36x43cm (VIVIX-S 3643FW), and 43x43cm (VIVIX-S 4343FW).

Vieworks Wins FDA Approval for Its Newest VIVIX-S F series

VIVIX-S F series

1. FINEST Image Quality

  • High resolution images with 99µm pixel pitch
  • Semi-dynamic feature (multi-frame mode)
  • Anatomy-based image enhancement with photon-understanding AI solution
  • Advanced image processing technology (VXvue, Software-based Scatter Correction)

2. FINEST Durability

  • Unbreakable glass-free TFT (flexible TFT)
  • Excellent durability (1.5m drop tested, 400kg load limit)
  • IP67 water and dust resistance
  • Wider operating temperature

3. FINEST Usability

  • Lighter weight for greater portability
  • Convenient charging (wireless charging, separate battery charger, USB-C type, magnetic tether, cradle)
  • Long lasting battery life (16 hours with two batteries, hot-swap mode)
  • Easy usage with user-friendly functions (Fast and convenient detector sharing by NFC, OLED status screen)

Source: Vieworks Co., Ltd.
Post created : 349   
Comment
Continue Reading
RELATED NEWS
Last views